Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison.
Pierelli L, Perillo A, Greggi S, Salerno G, Panici PB, Menichella G, Fattorossi A, Leone G, Mancuso S, Scambia G. Pierelli L, et al. Among authors: perillo a. J Clin Oncol. 1999 Apr;17(4):1288. doi: 10.1200/JCO.1999.17.4.1288. J Clin Oncol. 1999. PMID: 10561191 Clinical Trial.
Peripheral blood progenitor cell collection after epirubicin, paclitaxel, and cisplatin combination chemotherapy using EPO-based cytokine regimens: a randomized comparison of G-CSF and sequential GM-/G-CSF.
Perillo A, Pierelli L, Scambia G, Serafini R, Paladini U, Salerno MG, Bonanno G, Fattorossi A, Leone G, Mancuso S, Menichella G. Perillo A, et al. Transfusion. 2001 May;41(5):674-80. doi: 10.1046/j.1537-2995.2001.41050674.x. Transfusion. 2001. PMID: 11346705 Clinical Trial.
Administration of low-dose interleukin-2 plus G-CSF/EPO early after autologous PBSC transplantation: effects on immune recovery and NK activity in a prospective study in women with breast and ovarian cancer.
Perillo A, Pierelli L, Battaglia A, Salerno MG, Rutella S, Cortesi E, Fattorossi A, De Rosa L, Ferraù F, Lalle M, Leone G, Mancuso S, Scambia G. Perillo A, et al. Bone Marrow Transplant. 2002 Nov;30(9):571-8. doi: 10.1038/sj.bmt.1703687. Bone Marrow Transplant. 2002. PMID: 12407431 Clinical Trial.
The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and GM-CSF.
Pierelli L, Perillo A, Ferrandina G, Salerno G, Rutella S, Fattorossi A, Battaglia A, Rughetti A, Nuti M, Cortesi E, Leone G, Mancuso S, Scambia G. Pierelli L, et al. Among authors: perillo a. Transfusion. 2001 Dec;41(12):1577-85. doi: 10.1046/j.1537-2995.2001.41121577.x. Transfusion. 2001. PMID: 11778075 Clinical Trial.
In vitro effect of amifostine on haematopoietic progenitors exposed to carboplatin and non-alkylating antineoplastic drugs: haematoprotection acts as a drug-specific progenitor rescue.
Pierelli L, Scambia G, Fattorossi A, Bonanno G, Battaglia A, Perillo A, Menichella G, Panici PB, Leone G, Mancuso S. Pierelli L, et al. Among authors: perillo a. Br J Cancer. 1998 Oct;78(8):1024-9. doi: 10.1038/bjc.1998.622. Br J Cancer. 1998. PMID: 9792145 Free PMC article.
86 results